About Careers Internship MedBlog Contact us

Antibiotic Worsens Lou Gehrig's Disease

by Medindia Content Team on November 2, 2007 at 6:57 PM
Antibiotic Worsens Lou Gehrig's Disease

An antibiotic tested on patients with Lou Gehrig's disease in the hope that it can slow this crippling disorder of the nervous system in fact worsens symptoms, a study released on Wednesday said.

The drug, minocycline, was tested on human volunteers with amyotrophic lateral sclerosis (ALS), as Lou Gehrig's is called, and doctors are testing it on several other diseases of the nervous system.


These trials were launched after tests on lab-dish cells and on mice engineered to have ALS symptoms suggested minocycline could inhibit inflammation and apoptosis -- the process by which nerve cells are ordered to commit suicide.

But in a study published by The Lancet Neurology, US researchers found that ALS patients who took minocycline deteriorated 25-percent faster than counterparts who took a dummy lookalike pill, called a placebo.

"Our finding that minocycline has a harmful effect on patients with ALS has implications for trials of minocycline with other neurological disorders, and for how potential neuroprotective agents are screened for us in patients with ALS," says the study, lead-authored by Paul Gordon of New York's Columbia University.

Minocycline is a second-generation, broad-spectrum member of the tetracycline family, used in a wide range of bacterial infections.

Lou Gehrig's is a currently incurable but also enigmatic disease. It occurs when nerve cells die out, leaving the brain less and less able to control muscles and leading ultimately to paralysis.

Only about 10 percent of patients have a known family history of ALS, which thus causes the finger of blame to point at environmental factors.

Gordon's team enrolled 412 ALS patients, who were randomly assigned to receive a placebo or minocycline in escalating doses of up to 400 milligrams per day for nine months.

It was a Phase III trial, the widest, final step in a process to see whether a new treatment is safe and effective.

Patients were assessed according to standard measurements for coordination and muscle strength, as well as a "quality of life" questionnaire.

Several Phase II and Phase III trials are either planned or underway to look at minocycline's effect on Huntington's disease, stroke, dementia and multiple sclerosis, their paper said.

Source: AFP
Font : A-A+



Recommended Readings

Latest Research News

Cerebrospinal Fluid Leaks: Link to Traumatic Brain Injury and Dementia?
Cerebrospinal fluid (CSF) leaks are detected in approximately 1-3% of adults who have experienced a traumatic brain injury.
Astrocyte Activation Through Optogenetics: A New Hope in the Fight Against Alzheimer's
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
Link Between Cholesterol and Inflammation in Alzheimer's Disease Identified
In Alzheimer's disease condition, the control and adjustment of ABCA7 levels in response to inflammation and the decrease in the availability of cholesterol.
Inflammatory Bowel Disease and Atopic Dermatitis Share Common Links
Atopic dermatitis (AD) and inflammatory bowel disease (IBD) can lead to alterations in the microbiome, and disruptions in the skin and gut barrier.
Vitiligo-Associated Autoimmunity Linked to Lower Health Risks
Gaining insights into mortality risks among vitiligo patients will enhance patient counseling, healthcare monitoring, and overall patient management strategies.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Antibiotic Worsens Lou Gehrig's Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests